On March 20, 2026, the Food Standards Agency (FSA) published supplementary guidance for novel food applications involving products derived from precision fermentation and biomass fermentation. The guidance applies immediately and is intended to support businesses preparing dossiers under the UK novel foods framework by clarifying regulatory expectations and highlighting common deficiencies that delay assessments.
Details of the Update
The guidance emphasizes that applicants must provide a product-specific narrative, rather than relying on generic or incomplete datasets. It outlines how assessors interpret critical components such as identity, characterisation, manufacturing processes, stability, proposed uses, protein digestibility, and allergenicity.
In particular, the FSA highlights that whole genome sequencing should be treated as a baseline tool for production organism characterisation, with detailed expectations around plasmids, genetic modifications, phylogenetics, genome completeness, and the use of recognised databases.
The document also reinforces the need for robust manufacturing and compositional evidence, including validation of kill steps, confirmation of absence of viable production organisms, and assessment of residual DNA and host proteins, supported by batch-level data.
For products contributing meaningfully to dietary protein intake, the FSA expects protein digestibility assessment, identifying DIAAS as the preferred endpoint, and favouring INFOGEST-style in vitro digestion methods.
In addition, allergenicity assessment must go beyond sequence matching and consider protein structure, function, post-translational modifications, digestibility, intended use conditions, and the relevance of any remaining host proteins.
Effective Timeline
The guidance specifies that all bioinformatics analyses must be conducted within one year prior to application submission, ensuring that genome-based analyses and database searches remain current. While there is no formal application deadline, the guidance is immediately applicable and should be used for ongoing and future dossier preparation.
Why It Matters
This guidance increases regulatory clarity by defining more structured and detailed evidence of expectations for fermentation-derived novel foods. It reflects a shift toward data-intensive and method-specific assessments, supporting digital alignment in regulatory submissions while promoting efficiency in review processes. At the same time, it does not introduce new legal requirements, helping maintain a proportionate compliance burden while raising the quality threshold for submissions.
Who This Affects
This update is relevant for regulatory affairs, quality assurance, R&D, manufacturing, and scientific teams, as well as external partners involved in novel food dossier preparation, particularly those working with fermentation-derived ingredients or finished products.
Next Steps
Businesses should assess whether current or planned products fall within the novel foods regime and evaluate dossier readiness against this guidance. Regulatory teams are expected to collaborate with R&D, quality, and external experts to ensure coverage of key areas such as organism identification, genetic characterization, process validation, impurity testing, stability, intended use, nutritional assessment, and allergenicity.
Organizations should also ensure that scientific studies are initiated early, conducted using appropriate methodologies, and clearly linked to the final product and its intended use. Maintaining current bioinformatics data, ensuring batch-representative evidence, and presenting documentation in accepted formats will be critical to avoid delays in assessment.
As regulatory expectations for fermentation-based products become more rigorous, solutions that enhance visibility and coordination across regulatory workflows are increasingly important.
RegASK is a leading agentic AI regulatory intelligence and workflow orchestration platform that empowers global organizations in highly regulated sectors, including consumer products and life sciences, to proactively navigate complex regulatory landscapes. By combining advanced Agentic AI with experts in the loop, RegASK delivers timely predictive actionable insights and end-to-end automation, streamlining compliance processes, mitigating risks, and accelerating market access across more than 160 countries. Learn more or book a demo now.
FAQs
What is the purpose of the FSA supplementary guidance on novel foods?
The guidance clarifies how regulators assess precision fermentation and biomass fermentation products, highlighting evidence expectations and common gaps in dossier submissions.
Does this guidance introduce new legal requirements?
No. It is not a legislative change, but an interpretation document that signals the level of evidence expected in future submissions.
What are the key scientific requirements emphasized by the FSA?
Key requirements include whole genome sequencing, manufacturing validation, residual DNA and protein assessment, protein digestibility testing (DIAAS), and comprehensive allergenicity evaluation.
How can RegASK help with novel food regulatory compliance?
RegASK helps organizations track evolving regulatory expectations, structure compliant dossiers, and streamline cross-functional collaboration, ensuring that evidence generation and submission strategies align with the latest guidance.
Subscribe to the latest regulatory news
Curated newsletters
Relevant industry info
Access expert insights
